On Jun. 17, 2020, CureVac announced that the German Health Authority Paul-Ehrlich-Institute and the Belgian Federal Agency for…
On Jun. 17, 2020, Innovation Pharma reported receiving data from ongoing laboratory testing being conducted at a U.S….
On Jun. 17, 2020, Aclaris Therapeutics announced that the FDA had allowed an investigational new drug application to…
On Jun. 16, 2020, the FDA revoked the emergency use authorization (EUA) of the Chembio Diagnostic System DPP…
On Jun. 16, 2020, the All of Us Research Program, part of the National Institutes of Health, announced…
On Jun. 16, 2020, the University of Oxford reported that overall dexamethasone reduced the 28-day mortality rate by…
On Jun. 16, 2020, lower-income countries across the world have access life-saving pneumococcal conjugate vaccines, which protect against…
On Jun. 16, 2020, NanoString Technologies announced the availability of new solutions to study the immune response in…
On Jun. 15, 2020, the NIH announced it had launched a centralized, secure enclave to store and study…
On Jun. 15, 2020, the German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp,…
On Jun. 15, 2020, a team led by Scripps Research discovered antibodies in the blood of recovered COVID-19…
On Jun. 15, 2020, Eli Lilly announced that the first patient has been enrolled in a Phase 3…
On Jun. 15, 2020, Catalent announced that it will provide vial filling and packaging capacity to AstraZeneca at…
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
On Jun. 15, 2020, Cleveland Clinic researchers announced they had developed the worldï¾’s first risk prediction model for…
On Jun. 14, 2020, McKesson announced that it had expanded its existing partnership with the Centers for Disease…
On Jun. 13, 2020, AstraZeneca announced an agreement with Europeï¾’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France,…
On Jun. 13, 2020, officials from the WHO National Health Commission and Beijing Health Commission announced preliminary investigations…
On Jun. 13, 2020, Sinovac Biotech announced positive preliminary results of phase I/II clinical trial for the Companyï¾’s…
On Jun. 12, 2020, the FDA announced it had approved an expanded indication for Merck’s GARDASIL9 for the…
On Jun. 12, 2020, a tiny genetic mutation in the SARS coronavirus 2 variant circulating throughout Europe and…
On Jun. 12, 2020, Cue Health announced that it had received Emergency Use Authorization from the U.S. Food…
On Jun. 12, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
On Jun. 11, 2020, Atossa Therapeutics announced that the manuscript of the results from in vitro testing of…
On Jun. 11, 2020, scientists announced the development of a new test that can help identify people who…
On Jun. 11, 2020, the FDA approved Viela Bio’s Uplizna (inebilizumab-cdon) injection for intravenous use for the treatment…
On Jun. 11, 2020, scientists at the Universities of Oxford, Exeter, Yunnan and Bristol announced thay had discovered…
On Jun. 11, 2020, Sinovac Biotech announced the signing of a clinical development collaboration agreement to advance the…
On Jun. 11, 2020, Emergent BioSolutions announced deployment of its molecule-to-market contract development and manufacturing (CDMO) services to…
On Jun. 11, 2020, AIM ImmunoTech announced that it had filed a provisional patent application for, among other…